ArticleBMC pulmonary medicine2025
Prognosis of pulmonary embolism associated with syncope: a prospective cohort with the pulmonary embolism registry of Bogodogo university hospital /Burkina Faso.
Article in BMC pulmonary medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Syncope and In-Hospital Mortality in Pulmonary Embolism: Insights from 300 Patients.Life (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe prognosis value of syncope in pulmonary embolism remains uncertain. Our aim in this study is to investigate this question. MATERIALS AND
methodsThis was a prospective, single-center cohort study of pulmonary embolism from March 1, 2017 to June 31, 2022. Patients were subdivided into two groups according to whether or not they had syncope prior to being hospitalized: syncope (+) vs. syncope (-). Our study analysis aimed at identifying factors associated with the occurrence of syncope. Thereafter, it focused on determining whether syncope was an independent risk factor by using logistic regression that was specific to in-hospital death.
resultsFour hundred and fifty-one patients were included in the study, including 66 with syncope prior to hospitalization. The prevalence of this symptom during pulmonary embolism was of 14.63%. The variables associated with the occurrence of syncope were presence of proximal localization of the thrombus in pulmonary arteries, significant pulmonary hypertension, dilatation of the right heart chambers and a high severity index. Mortality in the syncope (+) group was significantly higher (24% vs. 9%; OR = 3,2 p < 0.001) in univariate analysis. After regression that was specific to in-hospital death, syncope was not found to be an independent death factor (OR = 1.03 [0.44; 2.42]; p = 0.60).
conclusionOur study shows that syncope is not an independent risk factor for death in PE. It is, however, associated with vulnerable conditions that place patients at high risk of early death.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.